SE9003903D0 - New pharmaceutical formulations - Google Patents

New pharmaceutical formulations

Info

Publication number
SE9003903D0
SE9003903D0 SE9003903A SE9003903A SE9003903D0 SE 9003903 D0 SE9003903 D0 SE 9003903D0 SE 9003903 A SE9003903 A SE 9003903A SE 9003903 A SE9003903 A SE 9003903A SE 9003903 D0 SE9003903 D0 SE 9003903D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical formulations
new pharmaceutical
substance
hydrophilid
ion
Prior art date
Application number
SE9003903A
Other languages
English (en)
Inventor
B M Lindstedt
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9003903A priority Critical patent/SE9003903D0/sv
Publication of SE9003903D0 publication Critical patent/SE9003903D0/sv
Priority to YU186791A priority patent/YU186791A/sh
Priority to SI9111867A priority patent/SI9111867B/sl
Priority to IE413691A priority patent/IE914136A1/en
Priority to HU9301671A priority patent/HU218661B/hu
Priority to EP91920634A priority patent/EP0560816B1/en
Priority to JP50011692A priority patent/JP3276956B2/ja
Priority to AT91920634T priority patent/ATE444737T1/de
Priority to AU89305/91A priority patent/AU656346B2/en
Priority to DE69133623T priority patent/DE69133623D1/de
Priority to PCT/SE1991/000814 priority patent/WO1992010171A1/en
Priority to CA002097176A priority patent/CA2097176C/en
Priority to US07/802,325 priority patent/US5707656A/en
Priority to PT99720A priority patent/PT99720B/pt
Priority to IS3787A priority patent/IS1749B/is
Priority to NO932053A priority patent/NO305536B1/no
Priority to FI932553A priority patent/FI932553A/fi
Priority to US08/216,028 priority patent/US5709882A/en
Priority to EE9400416A priority patent/EE03105B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
SE9003903A 1990-12-07 1990-12-07 New pharmaceutical formulations SE9003903D0 (sv)

Priority Applications (19)

Application Number Priority Date Filing Date Title
SE9003903A SE9003903D0 (sv) 1990-12-07 1990-12-07 New pharmaceutical formulations
YU186791A YU186791A (sh) 1990-12-07 1991-11-27 Nove farmaceutske formulacije koje sadrže farmaceutski aktivnu jonizujuću supstancu, kao i postupak za njihovo dobijanje
SI9111867A SI9111867B (en) 1990-12-07 1991-11-27 New pharmaceutical formulations containing active ionizable substance as well as procedure for their preparation
IE413691A IE914136A1 (en) 1990-12-07 1991-11-28 New pharmaceutical formulations containing a¹pharmacologically active ionizable substance as well as a¹process for the preparation thereof
EP91920634A EP0560816B1 (en) 1990-12-07 1991-12-03 New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof
AU89305/91A AU656346B2 (en) 1990-12-07 1991-12-03 New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof
CA002097176A CA2097176C (en) 1990-12-07 1991-12-03 New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof
JP50011692A JP3276956B2 (ja) 1990-12-07 1991-12-03 薬理学的に活性なイオン化可能物質を含有する新規な医薬製剤およびその製造法
AT91920634T ATE444737T1 (de) 1990-12-07 1991-12-03 Pharmakologisch aktive ionisierbare substanzen enthaltende neue pharmazeutische formulierungen sowie verfahren zu deren herstellung
HU9301671A HU218661B (hu) 1990-12-07 1991-12-03 Eljárás gyógyászatilag hatásos ionos hatóanyag és ioncserélő műgyanta komplexét tartalmazó gyógyszerformák előállítására
DE69133623T DE69133623D1 (de) 1990-12-07 1991-12-03 Haltende neue pharmazeutische formulierungen sowie verfahren zu deren herstellung
PCT/SE1991/000814 WO1992010171A1 (en) 1990-12-07 1991-12-03 New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof
US07/802,325 US5707656A (en) 1990-12-07 1991-12-04 Pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof
IS3787A IS1749B (is) 1990-12-07 1991-12-06 Aðferð til framleiðslu nýrra lyfjaforma, sem innihalda jónanleg, lyfjafræðilega virk efni
PT99720A PT99720B (pt) 1990-12-07 1991-12-06 Processo para a preparacao de novas composicoes farmaceuticas contendo uma substancia ionizavel com actividade farmacologica
NO932053A NO305536B1 (no) 1990-12-07 1993-06-04 FremgangsmÕte for fremstilling av et komprimert oralt preparat
FI932553A FI932553A (fi) 1990-12-07 1993-06-04 Nya farmaceutiska formulationer innehaollande ett farmakologiskt aktivtjoniserbart aemne samt process foer framstaellning daerav
US08/216,028 US5709882A (en) 1990-12-07 1994-03-22 Pharmaceutical formulations containing a pharmacologically active ionizable substance as well as a process for the preparation thereof
EE9400416A EE03105B1 (et) 1990-12-07 1994-11-17 Farmakoloogilist ioniseeruvat toimeainet sisaldavad ravimvormid ja nende valmistamise protsess

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003903A SE9003903D0 (sv) 1990-12-07 1990-12-07 New pharmaceutical formulations

Publications (1)

Publication Number Publication Date
SE9003903D0 true SE9003903D0 (sv) 1990-12-07

Family

ID=20381122

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9003903A SE9003903D0 (sv) 1990-12-07 1990-12-07 New pharmaceutical formulations

Country Status (17)

Country Link
US (2) US5707656A (sv)
EP (1) EP0560816B1 (sv)
JP (1) JP3276956B2 (sv)
AT (1) ATE444737T1 (sv)
AU (1) AU656346B2 (sv)
CA (1) CA2097176C (sv)
DE (1) DE69133623D1 (sv)
EE (1) EE03105B1 (sv)
FI (1) FI932553A (sv)
HU (1) HU218661B (sv)
IE (1) IE914136A1 (sv)
IS (1) IS1749B (sv)
NO (1) NO305536B1 (sv)
PT (1) PT99720B (sv)
SE (1) SE9003903D0 (sv)
WO (1) WO1992010171A1 (sv)
YU (1) YU186791A (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998027961A2 (en) * 1996-12-20 1998-07-02 Warner Lambert Company Antitussive drugs delivered by partially coated ion exchange resins
US20030118641A1 (en) * 2000-07-27 2003-06-26 Roxane Laboratories, Inc. Abuse-resistant sustained-release opioid formulation
EP1204406A2 (en) * 1999-07-29 2002-05-15 Roxane Laboratories, Inc. Opioid sustained-released formulation
EP1414458B1 (en) * 2001-07-06 2007-04-11 Endo Pharmaceuticals Inc. Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
US20030099711A1 (en) * 2001-08-29 2003-05-29 David Meadows Sustained release preparations
CA2481091A1 (en) * 2002-04-05 2003-10-23 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
JP2006296511A (ja) * 2005-04-15 2006-11-02 Transcutaneous Technologies Inc 外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ
JP2006346368A (ja) * 2005-06-20 2006-12-28 Transcutaneous Technologies Inc イオントフォレーシス装置及びその製造方法
EP1905433A1 (en) * 2005-07-15 2008-04-02 Transcu Ltd. Percutaneous absorption patch with application position indicating function, and iontophoresis device
JP2007037868A (ja) * 2005-08-05 2007-02-15 Transcutaneous Technologies Inc 経皮投与装置及びその制御方法
US8386030B2 (en) * 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US20070060860A1 (en) * 2005-08-18 2007-03-15 Transcutaneous Technologies Inc. Iontophoresis device
JPWO2007026671A1 (ja) * 2005-08-29 2009-03-05 Ｔｔｉ・エルビュー株式会社 センサからの情報により投与すべき薬剤の選定を行うイオントフォレーシス装置
NZ566628A (en) * 2005-09-16 2010-02-26 Tti Ellebeau Inc Catheter type iontophoresis apparatus using alternating layers of electrolytes and ion exchange membranes
US20070071807A1 (en) * 2005-09-28 2007-03-29 Hidero Akiyama Capsule-type drug-releasing device and capsule-type drug-releasing device system
WO2007038028A1 (en) * 2005-09-28 2007-04-05 Tti Ellebeau, Inc. Iontophoresis apparatus and method to deliver active agents to biological interfaces
WO2007037476A1 (ja) * 2005-09-30 2007-04-05 Tti Ellebeau, Inc. 睡眠導入剤と興奮剤の投与量および投与時期を制御するイオントフォレーシス装置
CA2622777A1 (en) * 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoresis device to deliver multiple active agents to biological interfaces
WO2007037475A1 (ja) * 2005-09-30 2007-04-05 Tti Ellebeau, Inc. 形状記憶セパレータを有するイオントフォレーシス用電極構造体およびそれを用いたイオントフォレーシス装置
US20070197955A1 (en) * 2005-10-12 2007-08-23 Transcutaneous Technologies Inc. Mucous membrane adhesion-type iontophoresis device
US20080193514A1 (en) * 2006-11-02 2008-08-14 Transcu Ltd. Compostions and methods for iontophoresis delivery of active ingredients through hair follicles
JPWO2008087803A1 (ja) * 2007-01-16 2010-05-06 国立大学法人北海道大学 抗酸化成分を封入したイオントフォレーシス用リポソーム製剤
JP2010187707A (ja) * 2007-06-12 2010-09-02 Hokkaido Univ インスリンを封入したイオントフォレーシス用リポソーム製剤
AU2009291764A1 (en) * 2008-09-10 2010-03-18 Transcu Ltd. Apparatus and method to dispense HPC-based viscous liquids into porous substrates, e.g., continuous web-based process
CA2757337A1 (en) 2009-04-03 2010-10-07 Coating Place, Inc. Modified-release pharmaceutical drug composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983392A (en) * 1983-11-14 1991-01-08 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
EP0199855A1 (en) * 1985-05-02 1986-11-05 Gist-Brocades N.V. Tablets comprising tromethoprim and a sulfonamide
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
IE62100B1 (en) * 1986-07-30 1994-12-14 Fisons Corp Coated ion exchange resins
DE3740684A1 (de) * 1987-12-01 1989-06-15 Woehr Otto Gmbh Parksystem
MC2025A1 (fr) * 1988-04-20 1990-04-25 Asta Pharma Ag Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof

Also Published As

Publication number Publication date
AU656346B2 (en) 1995-02-02
HUT64213A (en) 1993-12-28
DE69133623D1 (de) 2009-11-19
PT99720B (pt) 2002-04-29
WO1992010171A1 (en) 1992-06-25
NO932053D0 (no) 1993-06-04
PT99720A (pt) 1992-10-30
EP0560816B1 (en) 2009-10-07
JPH06503311A (ja) 1994-04-14
HU9301671D0 (en) 1993-09-28
NO932053L (no) 1993-07-20
HU218661B (hu) 2000-10-28
AU8930591A (en) 1992-07-08
JP3276956B2 (ja) 2002-04-22
CA2097176A1 (en) 1992-06-08
US5709882A (en) 1998-01-20
IE914136A1 (en) 1992-06-17
IS1749B (is) 2000-07-11
YU186791A (sh) 1994-04-05
ATE444737T1 (de) 2009-10-15
CA2097176C (en) 2002-03-26
US5707656A (en) 1998-01-13
NO305536B1 (no) 1999-06-21
IS3787A7 (is) 1992-06-08
FI932553A0 (fi) 1993-06-04
EP0560816A1 (en) 1993-09-22
FI932553A (fi) 1993-06-04
EE03105B1 (et) 1998-08-17

Similar Documents

Publication Publication Date Title
SE9003903D0 (sv) New pharmaceutical formulations
PT88404A (pt) Dosage form comprising fast agent delivery followed by slow agent delivery
NO851170L (no) Lagringsstabile, hurtignedbrytende farmasoeytiske virksomme stoff-presslegemer
ATE95983T1 (de) Graduelle verabreichungsstrukturen fuer kaugummi.
ES2190075T3 (es) Formulaciones farmaceuticas solidas que contienen una mezcla fisica de sulfoalquil-eter-ciclodextrina y un agente terapeutico.
YU174490A (sh) Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
BG47033A3 (en) Method for preparing of derivatives of imidazolamine
ES2173858T3 (es) Analogos de huperzina a.
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
DK0957981T3 (da) Rersorvoirer til aflevering af lægemidler ved elektrotransport, indeholdende inerte fyldmaterialer
HU9301672D0 (en) Method for manufacturing solid dosing forms of medicaments with controlled releasing of active agents
SE8901003D0 (sv) Snabbloesliga preparat
ES2195040T3 (es) Conjugado que incluye un principio activo, un polipeptido y varios polieteres y su uso como medicamento.
ATE254851T1 (de) Iod-herstellungszusammensetzung
SE9803272D0 (sv) A drug for cell regeneration
DE69714856D1 (de) Pharmazeutische zusammensetzung enthaltend einen embryonalen extrakt und verfahren zu ihrer herstellung
DK0450123T3 (da) Farmaceutisk præparat til topisk administration indeholdende dichlofenac-natrium
SE9902742D0 (sv) New pharmaceutical formultion
ES469749A1 (es) Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol.
BR9813037A (pt) Composto, processo para sua preparação, uso do mesmo, preparação farmacêutica, e, combinação desta com pelo menos uma outra substância ativa
AU476756B2 (en) PHARMACOLOGICALLY ACTIVE 4, 8-DIMETHOXY-FURO-(3',2'-F) BENZOXAZOL-2-yl ACETHYDROXAMIC ACID
CO4370014A1 (es) Soluciones inyectables estables de diritromicina
IT8720800A0 (it) Composto attivo nella terapia carciovascolare.
ATE206040T1 (de) Sulfatierte polyvinylalkoholpolymere zur stabilisierung von arzneimitteln